Contingency plans have been triggered to make sure NHS trusts keep receiving millions of examination gloves, after an unforeseen surge in demand caused “stock shortages” at their main supplier.
Leaders of a health economy which has been awarded only a fraction of the funds allocated through a new capital regime have claimed national bodies failed to fully consider their bids.
Two out of three requests from NHS trusts for capital investment have so far been rejected under the government’s new funding regime, analysis by HSJ suggests.
Financial penalties are being lifted from high-profile standards including cancer and elective waiting times, so far without attracting much attention. How is this happening? And will it work, asks Rob Findlay